Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Naltrexone in narcolepsy. Initial experience].

K Sonka, B Roth, M Posmurová

    Ceskoslovenska Neurologie a Neurochirurgie
    |October 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Naltrexone did not improve symptoms or weight in four narcolepsy-cataplexy patients over 13 days. No adverse effects were reported during this naltrexone treatment for narcolepsy.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Navigating Organizational Challenges and Formal Support for Afghan Refugee Women in California Amid Covid-19 and the Taliban's Takeover.

    International journal of social determinants of health and health services·2025
    Same author

    The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
    Same author

    Prevalence of overweight, obesity, and early adiposity rebound in nursery school children in southeastern France.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
    Same author

    WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
    Same author

    Surgical site infections: guidance for elective surgery during the SARS-CoV-2 pandemic - international recommendations and clinical experience.

    The Journal of hospital infection·2021
    Same author

    [Prioritization of intensive medical treatment places - Concept proposal].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2021
    Same journal

    [Low-molecular transfer factor and its use in the treatment of amyotrophic lateral sclerosis].

    Ceskoslovenska neurologie a neurochirurgie·1991
    Same journal

    [Somatosensory evoked potentials in workers exposed to toluene].

    Ceskoslovenska neurologie a neurochirurgie·1991
    Same journal

    [Cerebellar malacias in younger patients].

    Ceskoslovenska neurologie a neurochirurgie·1991
    Same journal

    [Anterior choroidal artery syndromes].

    Ceskoslovenska neurologie a neurochirurgie·1991
    Same journal

    [Tumor compression of the conus and cauda].

    Ceskoslovenska neurologie a neurochirurgie·1991
    Same journal

    [Computer tomography in the diagnosis of neuromuscular diseases in children].

    Ceskoslovenska neurologie a neurochirurgie·1991
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Context:

    • Narcolepsy-cataplexy is a chronic neurological disorder.
    • Current treatments for narcolepsy-cataplexy have limitations.

    Purpose:

    • To evaluate the efficacy of naltrexone in treating narcolepsy-cataplexy.

    Summary:

    • A 13-day administration of 550 mg naltrexone was given to four patients diagnosed with narcolepsy-cataplexy.
    • Naltrexone did not lead to symptom improvement, appetite increase, or body weight gain.
    • No adverse side effects were observed during the naltrexone treatment period.

    Impact:

    • Naltrexone at this dosage and duration showed no therapeutic benefit for narcolepsy-cataplexy symptoms or associated weight changes.
    • Further research may be needed to explore other dosages or patient populations.